EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

Title
EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 20, Issue 4, Pages 972-984
Publisher
American Association for Cancer Research (AACR)
Online
2013-12-19
DOI
10.1158/1078-0432.ccr-13-0709

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation